Advaita
Advaita provides pathway-analysis and multi-omics software for academic and life-science researchers, offering flagship iPathwayGuide, single-cell and spatial iSCanGuide, iBioGuide, iVariantGuide, and iKnowledgeBase through subscriptions, institutional access, and per-analysis pricing options.
- Company typePrivate
- Founded2006
- HeadquartersAnn Arbor, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Advaita does
Advaita is described as a private bioinformatics company founded in 2006/2007 and headquartered in Ann Arbor, Michigan, with 11-50 employees. It serves academic and life-science researchers through pathway-analysis and multi-omics software, including iPathwayGuide, iSCanGuide, iBioGuide, iVariantGuide, and iKnowledgeBase. Its commercial model combines a $287 single-analysis purchase, subscriptions, institutional offerings, and a free iBioGuide, with an API also identified for batch processing.
The input describes iPathwayGuide as the flagship product, a weekly-updated knowledge base integrating 20+ databases, and iSCanGuide as a single-cell and spatial offering supported by GPU-accelerated infrastructure. It reports 13,000+ registered users, 19,900+ citations, and 800+ publications. The material also lists approximately $1.2 million in NSF grants across 2017, 2019, and 2020 and says no VC/PE funding is disclosed. No WX source identifier appears in the input, so these statements are unverified in this extraction.
Advaita firmographics
Firmographics- Name
- Advaita
- Legal name
- Advaita Corporation
- Website
- https://advaitabio.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Advaita provides pathway-analysis and multi-omics software for academic and life-science researchers, offering flagship iPathwayGuide, single-cell and spatial iSCanGuide, iBioGuide, iVariantGuide, and iKnowledgeBase through subscriptions, institutional access, and per-analysis pricing options.
- Ownership category
- akta.pro rank
Advaita industry classification
Industry- Product category
- Bioinformatics Software
- NAICS
- Software Publishers (5132), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
- akta.pro secondary industries
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Single-Cell & Spatial Omics Discovery Platforms (target ID/validation, functional profiling) (HLAAAIAF), Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation) (HLAAAIAI)
Keywords
Where Advaita is headquartered
LocationHeadquarters
- HQ city
- Ann Arbor
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Advaita business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- iPathwayGuide Subscriptions: Subscription-based access to platform with per-user and volume-based pricing. Includes unlimited analyses at fixed cost. Annual and multi-year contract options available for academic and enterprise customers.
- Single Analysis Purchase: One-time purchase of individual analyses at USD 287 per analysis (as of June 2019). Suitable for researchers with occasional analysis needs.
- Departmental/Institution-wide Licenses: Volume-based pricing scales with number of users and volume of analyses. Contact sales for enterprise-wide deployment options.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Single Analysis |
| Subscription | Annual | Subscription (Annual) |
| Freemium | Monthly | Free Tier (iBioGuide) |
| Subscription | Annual | Departmental/Institution-wide |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Advaita product offering
Product offeringCore offering
Advaita develops and operates cloud-based bioinformatics analysis platforms that transform multi-omics, single-cell, and spatial transcriptomics datasets into biologically meaningful interpretations. Its flagship products are iPathwayGuide (multi-omics pathway and systems analysis using proprietary Impact Analysis methodology) and iSCanGuide (GPU-accelerated single-cell and spatial transcriptomics analysis), complemented by iBioGuide (free search tool), iVariantGuide (variant interpretation), and iKnowledgeBase (curated research databases). The platforms serve academic researchers, core facilities, CROs, and biotech/pharmaceutical enterprise teams with subscription and per-analysis pricing.
Product overview
Advaita Bio offers a bioinformatics platform suite centered on two flagship products: iPathwayGuide™ for multi-omics pathway and systems analysis using proprietary Impact Analysis, and iSCanGuide™ for GPU-accelerated single-cell and spatial transcriptomics. The platform is augmented by complementary tools including iBioGuide (free search engine), iVariantGuide (variant interpretation), and iKnowledgeBase (curated database). The architecture integrates these tools—iSCanGuide connects to iPathwayGuide to extend analysis from raw transcriptomics to biological interpretation—unified through cloud-based delivery requiring no local installation.
Differentiator
Problem solved
Functional benefit
Brands
- iPathwayGuide: Multi-omics pathway and systems analysis platform using proprietary Impact Analysis methodology for pathway analysis, gene ontology analysis, disease analysis, and upstream regulator analysis.
- iSCanGuide
- iBioGuide
- iVariantGuide
- iKnowledgeBase
Products and services
- iPathwayGuide Multi-omics pathway and systems analysis platform using proprietary Impact Analysis methodology for transcriptomics, proteomics, epigenomics, and methylomics data interpretation. Supports human, mouse, and rat organisms and provides gene ontology analysis, pathway analysis, predicted miRNA analysis, disease analysis, and drug response predictions. Used by academic researchers, core facilities, and pharma research teams.
- iSCanGuide GPU-optimized cloud platform for large-scale single-cell and spatial transcriptomics analysis with no-code GUI interface, standardized reproducible workflows, support for 10x Genomics Visium and Xenium formats, and integrated cell-to-cell communication analysis. Designed for researchers working with high-throughput single-cell and spatial datasets.
- iBioGuide Free browser-based search tool built on Advaita's knowledge base of over 100 million biological relationships. Allows users to search for genes, microRNAs, pathways, biological processes, molecular functions, cellular components, drugs, diseases, and references. No email required to use.
- iVariantGuide Variant analysis and interpretation platform that takes VCF files, annotates them with multiple sources, and provides interactive filters for exploring relationships between biological features and effects. Includes advanced pruning algorithms for eliminating false positives in GO analysis. Accessible via API for batch processing.
- iKnowledgeBase Curated research knowledge base containing integrated databases for genes, pathways, diseases, drugs, microRNAs, GO terms, and molecular interactions, updated weekly with 20+ integrated sources plus a proprietary layer.
Quantifiable outcome
- Analysis completed in ~15 minutes versus potentially days of manual work
- +2 more outcomes
Companies that use Advaita
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Advaita technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature6 records
Advaita partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered regional and core.
- Inqaba Biotechnical IndustriesregionalDistribution partnership providing advanced pathway analysis software access to researchers in Sub-Saharan Africa. Inqaba Biotechnical Industries serves as the authorized distributor for the region.
- SCIEXcoreCollaboration enabling users to bring SWATH proteomics data from SCIEX workflow and analyze it in the context of pathways, gene ontologies, microRNAs, and diseases within iPathwayGuide. Combines protein expression experiments with RNA-Seq, microarrays, and targeted panels.
- Wayne State UniversitycoreAcademic origin of the technology. Dr. Sorin Draghici developed the Impact Analysis method at Wayne State University's Intelligent Systems and Bioinformatics Laboratory. Ongoing academic affiliation with Dr. Draghici serving as Professor of Computer Science and Obstetrics and Gynecology.
- National Science Foundation (NSF)coreDr. Sorin Draghici serves as Program Director at NSF since July 2022. Represents academic-government partnership and scientific credibility.
Scale indicators6 records
Expansion highlights6 records
Advaita competitors and assessment
Company assessmentDirect peers
- QIAGEN Digital Insights (Ingenuity Pathway Analysis): QIAGEN's Ingenuity Pathway Analysis (IPA) is the most entrenched commercial pathway and multi-omics interpretation platform, directly competing with iPathwayGuide across transcriptomics, proteomics, and upstream regulator analysis for both academic and pharma customers.
- Illumina (Partek Flow): Illumina acquired Partek, a genomics/bioinformatics software suite offering pathway and single-cell analysis — a direct competitor in cloud-based omics interpretation, now backed by Illumina's sequencing installed base.
- Velsera (formerly Seven Bridges): Velsera operates a cloud bioinformatics platform for multi-omics and single-cell analysis with API-accessible workflows, directly comparable to Advaita's cloud-delivered, no-code analysis positioning for cores, CROs, and enterprise teams.
- DNAnexus: DNAnexus provides a regulated (HIPAA/FedRAMP) cloud bioinformatics platform for omics data processing and analysis, competing with Advaita for translational and pharma enterprise workloads that require compliant, programmatic, multi-omics pipelines.
Emerging players
- Broad Institute (GSEA / MSigDB): GSEA and the MSigDB molecular signature database are the de facto open-standard pathway and enrichment analysis tooling, competing head-on with iPathwayGuide's enrichment analysis layer and influencing academic purchasing decisions.
- Rosalind (BioSpecimen / single-cell analysis): Rosalind offers a cloud-based, no-code bioinformatics platform with single-cell and pathway analysis capabilities, competing with iSCanGuide/iPathwayGuide in the no-code, multi-omics experience for academic and translational researchers.
- Metascape: Metascape is a widely adopted free academic pathway analysis tool with multi-omics support; it competes with iPathwayGuide for academic PIs who might otherwise adopt a paid commercial alternative if pricing pressure exists.
Broad incumbents
- Benchling: Benchling is a broader cloud R&D platform for life sciences that includes registry, assay, and increasingly informatics workflows — an incumbent adjacent to Advaita that competes for biotech enterprise IT budgets and could expand into omics interpretation.
- 10x Genomics (Cloud Analysis / Loupe): 10x Genomics bundles proprietary single-cell and spatial analysis software with its instruments; its cloud analysis offerings directly overlap with iSCanGuide for Visium and Xenium users, and 10x's installed base gives it a structural advantage.
- Dotmatics: Dotmatics provides an end-to-end scientific R&D platform spanning informatics, biology, and chemistry; its biology and omics modules overlap with Advaita's pathway and multi-omics interpretation positioning for pharma R&D.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Advaita social profiles
Digital presenceAdvaita compliance and trust
Trust signalCompliance1 record
Advaita financial estimates
Financial estimateRevenue estimate
Valuation estimate
Advaita leadership team
Management profileNumber of profiles
Profiles7 records
Advaita funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Advaita M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Advaita
What does Advaita do?
Advaita develops and operates cloud-based bioinformatics analysis platforms that transform multi-omics, single-cell, and spatial transcriptomics datasets into biologically meaningful interpretations. Its flagship products are iPathwayGuide (multi-omics pathway and systems analysis using proprietary Impact Analysis methodology) and iSCanGuide (GPU-accelerated single-cell and spatial transcriptomics analysis), complemented by iBioGuide (free search tool), iVariantGuide (variant interpretation), and iKnowledgeBase (curated research databases). The platforms serve academic researchers, core facilities, CROs, and biotech/pharmaceutical enterprise teams with subscription and per-analysis pricing.
Is Advaita a public or private company?
Advaita is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Advaita founded?
Advaita was founded in 2006. It employs 11 to 50 people.
Where is Advaita based?
Advaita is headquartered in Ann Arbor, United States, in the North America region.
How does Advaita make money?
Three revenue lines are on record. iPathwayGuide Subscriptions are the primary driver. The others are single Analysis Purchase and departmental/Institution-wide Licenses.
Who are Advaita's main competitors?
Direct peers on record are QIAGEN Digital Insights (Ingenuity Pathway Analysis), Illumina (Partek Flow), Velsera (formerly Seven Bridges) and DNAnexus. Emerging players are Broad Institute (GSEA / MSigDB), Rosalind (BioSpecimen / single-cell analysis) and Metascape. Broad incumbents are Benchling, 10x Genomics (Cloud Analysis / Loupe) and Dotmatics.
Does Advaita have an API?
Yes. Advaita offers an API for programmatic access to iPathwayGuide and iVariantGuide. The API enables users to submit analyses programmatically in batch mode, automating workflows that would otherwise require manual configuration. Users can launch multiple comparisons programmatically instead of setting everything up manually, significantly increasing productivity for groups with large analysis volumes. Developer documentation is at apps.advaitabio.com/oauth-provider/login.
What industry is Advaita in?
Advaita's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 5132 and its SIC code is 7372.